Gene editing in translational research
DOI:
https://doi.org/10.1344/rbd2019.0.28570Palabras clave:
Genome editing, CRISPR, germline editing, synthetic biology, biotechnologyResumen
DNA read and write technologies have accelerated biotechnology at an unprecedented pace. This enhanced capacity to engineer living beings has accelerated not only scientific research, but also the translation into novel therapies. New approved medicinal products include the correction of the diseased genome and synthetic enhancement to fight diseases. These practices are widely supported socially and scientifically. Applications beyond therapy have also be attempted. In 2018, researcher He Jiankui reported on the edition of human germline during the Second International Summit on Human Genome Editing. On the other hand, during the last years, there have also been attempts at somatic genetic enhancement without the provision of detailed outcomes. Reading and writing DNA empowers us to change our world, even ourselves. The social benefits may be enormous. We need to accelerate the debate, including the stakeholders, to foster a responsible use of these technologies and maximize the positive impact on society.
Citas
ADLI, Mazhar. 2018. “The CRISPR Tool Kit for Genome Editing and beyond.” Nature Communications 9 (1): 1911.
ARISTIZABAL, Ana María; CAICEDO, Luis Armando; MARTÍNEZ, Juan Manuel; MORENO, Manuel and ECHEVERRI, Gabriel J. 2017. “Clinical Xenotransplantation, a Closer Reality: Literature Review.” Cirugía Española 95 (2): 62–72.
BALTIMORE, David; BAYLIS, Françoise; BERG, Paul; DALEY, George Q.; DOUDNA, Jennifer A.; LANDER, Eric S.; LOVELL-BADGE, Robin et al. 2015. On Human Gene Editing: International Summit Statement”. Washington DC: National Academy of Sciences.
BANKS, Marcus. 2018. “First CRISPR Clinical Trial Begins in Europe” Scienceline. November 12, 2018.
CASTELLARIN, Mauro; WATANABE, Keisuke; JUNE, Carl H.; KLOSS, Christopher C., and POSEY, Avery D. 2018. “Driving Cars to the Clinic for Solid Tumors.” Gene Therapy 25 (3): 165–75.
CHECK, Erika. 2002. “Gene Therapy: A Tragic Setback.” Nature 420 (6912): 116–18.
CONG, Le, F.; RAN, Ann; COX, David; LIN, Shuailiang; BARRETTO, Robert; HABIB, Naomi; HSU, Patrick D., et al. 2013. “Multiplex Genome Engineering Using CRISPR/Cas Systems.” Science 339 (6121): 819–23.
DARIE, Tatiana. 2019. “UPenn Treats First Cancer Patients in Crispr-Based Trial.” Bloomberg News, April 16, 2019.
NATIONAL HUMAN GENOME RESEARCH INSTITUTE. 2019. DNA Sequencing Costs: Data. Accessed April 29, 2019.
FRENCH, K. E. 2019. “Harnessing Synthetic Biology for Sustainable Development.” Nature Sustainability 2 (4): 250–52.
NATURE (editorial). 2016. “Gene-Therapy Trials Must Proceed with Caution.” Nature 534 (7609): 590.
GIBSON, Daniel G.; BENDERS, Gwynedd A.; AXELROD, Kevin C.; ZAVERI, Jayshree; ALGIRE, Mikkel A.; MOODIE, Monzia; MONTAGUE, Michael G.; VENTER, J. Craig; SMITH, Hamilton O.; HUTCHISON, Clyde A. 2008. “One-Step Assembly in Yeast of 25 Overlapping DNA Fragments to Form a Complete Synthetic Mycoplasma Genitalium Genome.” Proceedings of the National Academy of Sciences of the United States of America 105 (51): 20404–9.
GINN, Samantha L.; AMAYA, Anais K.; ALEXANDER, Ian E.; EDELSTEIN, Michael, and ABEDI, Mohammad R. 2018. “Gene Therapy Clinical Trials Worldwide to 2017: An Update.” The Journal of Gene Medicine 20 (5): e3015.
GÜELL, Marc; NIU, Dong; KAN, Yinan; GEORGE, Haydy; WANG, Tao; LEE, I-Hsiu; WANG, Gang; CHURCH, George; YANG, Luhan. 2017. “PERV Inactivation Is Necessary to Guarantee Absence of Pig-to-Patient PERVs Transmission in Xenotransplantation.” Xenotransplantation 24 (6): e12366.
HARARI, Yuval Noah. 2016. Homo Deus: A Brief History of Tomorrow. Random House.
HUMAN MICROBIOME PROJECT CONSORTIUM. 2012. “Structure, Function and Diversity of the Healthy Human Microbiome.” Nature 486 (7402): 207–14.
IRELAND, Tom. 2017. “‘I Want to Help Humans Genetically Modify Themselves.’” The Guardian, December 24, 2017.
ISABELLA, Vincent M.; HA, Binh N.; CASTILLO, Mary Joan; LUBKOWICZ, David J.; ROWW, Sarah E.; MILLET, Yves A.; ANDERSON, Cami L., et al. 2018. “Development of a Synthetic Live Bacterial Therapeutic for the Human Metabolic Disease Phenylketonuria.” Nature Biotechnology 36 (9): 857–64.
IWASE, Hayato; HARA, Hidetaka; EZZELARAB, Mohamed; LI, Tao, ZHANG, Zhongqiang, GAO, Bingsi; LIU, Hong Liu et al. 2017. “Immunological and Physiological Observations in Baboons with Life-Supporting Genetically Engineered Pig Kidney Grafts.” Xenotransplantation 24 (2): 1–13.
BRUNO BERNARDES DE, Jesus; VERA, Elsa; SCHNEEBERGER, Kerstin; TEJERA, Agueda M.; AYUSO, Eduard; BOSCH, Fatima; BLASCO, Maria A. 2012. “Telomerase Gene Therapy in Adult and Old Mice Delays Aging and Increases Longevity without Increasing Cancer.” EMBO Molecular Medicine 4 (8): 691–704.
MARTIN, Jinek; CHYLINSKI, Krzysztof; FONFARA, Ines; HAUER, Michael; DOUDNA, Jennifer A.; CHARPENTIER, Emmanuelle. 2012. “A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity.” Science 337 (6096): 816–21.
TASUKU, Kitada; DiANDRETH, Breanna; TEAGUE, Brian; WEISS, Ron. 2018. “Programming Gene and Engineered-Cell Therapies with Synthetic Biology.” Science 359 (6376).
KUHLMANN, Anne-Sophie; PETERSON, Christopher W.; KIEM, Hans-Peter. 2018. “Chimeric Antigen Receptor T-Cell Approaches to HIV Cure.” Current Opinion in HIV and AIDS 13 (5): 446–53.
KURTZ, Caroline B.; MILLET, Yves A.; PUURUNEN, Marja K.; PERREAULT, Mylène; CHARBONNEAU, Mark R.; ISABELLA, Vincent M.; KOTULA, Jonathan W., et al. 2019. “An Engineered E. Coli Nissle Improves Hyperammonemia and Survival in Mice and Shows Dose-Dependent Exposure in Healthy Humans.” Science Translational Medicine 11 (475).
LÄNGIN, Matthias; MAYR, Tanja; REICHART, Bruno; MICHEL, Sebastian; BUCHHOLZ, Stefan; GUETHOFF, Sonja; DASHKEVICH, Alexey, et al. 2018. “Consistent Success in Life-Supporting Porcine Cardiac Xenotransplantation.” Nature 564 (7736): 430–33.
MAEDER, Morgan L.; STEFANIDAKIS, Michael; WILSON, Christopher J.; BARAL, Reshica; BARRERA, Luis Alberto; BOUNOUTAS, George S.; BUMCROT, David; et al. 2019. “Development of a Gene-Editing Approach to Restore Vision Loss in Leber Congenital Amaurosis Type 10.” Nature Medicine 25 (2): 229–33.
PRASHANT, Mali; YANG, Luhan; ESVELT, Kevin; AACH, John; GUELL, Marc; DiCARLO, James E.; NORVILLE, Julie E.; CHURCH, George M. 2013. “RNA-Guided Human Genome Engineering via Cas9.” Science 339 (6121): 823–26.
SHANNON L., Maude; FREY, Noelle; SHAW, Pamela A.; APLENC, Richard; BARRETT, David M.; BUNIN, Nancy J.; CHEW, Anne; et al. 2014. “Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia.” The New England Journal of Medicine 371 (16): 1507–17.
MARK, Mimee; CITORIK, Robert J.; LU Timothy K. 2016. “Microbiome Therapeutics - Advances and Challenges.” Advanced Drug Delivery Reviews 105 (Pt A): 44–54.
DONG, Niu; WEI, Hong-Jiang; LIN, Lin; GEORGER, Haydy; WANG, Tao; LEE, I-Hsiu; ZHAO, Hong-Ye, et al. 2017. “Inactivation of Porcine Endogenous Retrovirus in Pigs Using CRISPR-Cas9.” Science 357 (6357): 1303–7.
NILI, Ostrov; LANDON, Matthieu; GUELL, Marc; KUZNETSOV, Gleb; TERAMOTO, Jun; CERVANTES, Natalie; ZHOU, Minerva, et al. 2016. “Design, Synthesis, and Testing toward a 57-Codon Genome.” Science 353 (6301): 819–22.
PRETORIUS, I. S.; BOEKE, J. D. 2018. “Yeast 2.0—connecting the Dots in the Construction of the World’s First Functional Synthetic Eukaryotic Genome.” FEMS Yeast Research.
REGALADO, Antonio.n.d. MIT Technology Review. Accessed April 30, 2019.
SCHWAB, Klaus. 2017. The Fourth Industrial Revolution. Crown Publishing Group.
SHENDURE, Jay,; PORRECA, Gregory J.; REPPAS, Nikos B.; LIN, Xiaoxia; McCUTCHEON, John P.; ROSENBAUM, Abraham M.; WANG, Michael D.; KUN ZHANG, Wang; MITRA, Robi D.; CHURCH, George M. 2005. “Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome.” Science 309 (5741): 1728–32.
SHERIDAN, Cormac. 2018. “Go-Ahead for First in-Body CRISPR Medicine Testing.” Nature Biotechnology News. December 14, 2018.
SMALLEY, Eric. 2017. “First AAV Gene Therapy Poised for Landmark Approval.” Nature Biotechnology 35 (11): 998–99.
“Transplant Trends - UNOS.” n.d. UNOS. Accessed April 29, 2019.
TSANG, Stephen H.; SHARMA, Tarun. 2018. “Leber Congenital Amaurosis.” Advances in Experimental Medicine and Biology 1085: 131–37.
XU, Lei; YANG, Huan; GAO; Yang; CHEN, Zeyu; XIE, Liangfu; LIU, Yulin; LIU, Ying, et al. 2017. “CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.” Molecular Therapy: The Journal of the American Society of Gene Therapy 25 (8): 1782–89.
LUHAN, Yang; GUELL, M.; XIU, Dong Niu; GEORGE, Haydy; LESHA, Emal; GRISHIN, Dennis; AACH, John, et al. 2015. “Genome-Wide Inactivation of Porcine Endogenous Retroviruses (PERVs).” Science 350 (6264): science.aad1191.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Las/os autoras/es conservan los derechos de autoría de los artículos y autorizan a la Universitat de Barcelona a publicarlos en su Revista de Bioética y Derecho y a incluirlos en los servicios de indexación y abstracts, bases de datos académicas y repositorios en los que participa la revista.
Los trabajos publicados en la Revista de Bioética y Derecho están bajo la licencia Creative Commons Reconocimiento - NoComercial - SinObraDerivada 4.0 Internacional (by-nc-nd 4.0), que permite compartir la obra con terceros, siempre que éstos reconozcan su autoría, su publicación inicial en esta revista y las condiciones de la licencia. No se permite un uso comercial de la obra original ni la generación de obras derivadas.
